<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02815618</url>
  </required_header>
  <id_info>
    <org_study_id>BabyLux CIP 4.1</org_study_id>
    <nct_id>NCT02815618</nct_id>
  </id_info>
  <brief_title>An Optical Neuro-monitor of Cerebral Oxygen Metabolism and Blood Flow for Neonatology</brief_title>
  <acronym>BabyLux</acronym>
  <official_title>An Optical Neuro-monitor of Cerebral Oxygen Metabolism and Blood Flow for Neonatology</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Gorm Greisen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rigshospitalet, Denmark</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Feasibility trial on the use of a hybrid optical device integrating time-resolved
      near-infrared spectroscopy (TRS) and diffuse correlation spectroscopy (DCS) for measurement
      of cerebral oxygen metabolism and blood flow in neonates.

      The device wil be tested in four settings measuring:

        1. Changes in cerebral oxygenation and haemodynamics after birth

        2. precision and repeatability

        3. The cerebral vaso-reactivity to arterial carbon dioxide

        4. Assessment of the user-friendliness and loss of signal in routine care
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The BabyLux project aims to provide a precise, accurate, and robust device to continuously
      monitor cerebral oxygen metabolism and blood flow in critically ill newborn infants. This
      will be achieved by combining time resolved near-infrared spectroscopy (TRS) with newly
      developed diffuse correlation spectroscopy (DCS) in a single device. The innovative aspects
      of the project are related to the use of advanced solutions, based on state-of-the-art
      photonic components, which have already been tested in laboratory and clinical tests on
      adults.

      Time Resolved Near-infrared spectroscopy and Diffuse Correlation Spectroscopy

      The proposed solution will integrate two advanced photonic techniques, TRS and DCS. Both
      techniques rely on the use of an optical fibre probe (sensor) to illuminate with very low
      power near-infrared light the scalp and to collect the diffusively reflected optical signal
      that has propagated through the scalp and skull, and therefore carries information on the
      deeper cortical region. The different absorption spectra of oxygenated and deoxygenated
      haemoglobin in the near-infrared range allows for the non-invasive monitoring of the two
      species in the cortical tissue.

      TRS and DCS prototypes are available and have been technically tested in laboratory settings
      and successfully validated during preclinical trials on adult volunteers and patients.

      Measured TRS/DCS parameters

      TRS measures the attenuation and the temporal broadening of relatively short light pulses
      (pulse duration ~100 ps) through a diffusive medium (e.g. a neonate's head). TRS has the
      ability to resolve path-lengths (or equivalently time-of-flights) of photons that have
      propagated through the tissues. This enables TRS to separate the absorption and scattering
      coefficients allowing for absolute measurements, and to utilize time-gating of path-lengths
      to emphasize signals from deeper tissues. This is particularly important for separating
      intra- and extra-cerebral signals for brain monitoring.

      DCS relies on the fact that temporal correlation of light fields in turbid media also obeys a
      diffusion equation, albeit a slightly different one than is used for TRS. Thus DCS shares the
      light penetration advantages of TRS, but, since DCS explicitly measures red blood cell
      movement, it provides a direct measure of quantities such as cerebral blood flow (CBF).

      The specific combination of DCS and TRS allows for the assessment of cerebral oxygen
      metabolism and CBF in a complete (i.e. CBF and oxygenation are simultaneously and
      independently provided), accurate (i.e. based on absolute measurements of optical parameters)
      and robust (i.e. potentially less affected by artefacts related to superficial systemic
      activity or sensor/head movements) way.

      The aim of this study is to perform clinical measurements using the BabyLux instrument in
      different clinical real-life settings to validate this new technology in terms of
      feasibility, repeatability of measurements, and user friendliness in neonatal medicine.

      The BabyLux system is tested in four different real-life settings to measure:

        1. The increase in oxygenation and change in blood flow during the minutes after birth to
           specify the expected range of measurement;

        2. The precision and repeatability of measurements by reapplying the NIRS sensor several
           times on slightly different sites of the head in a relatively steady condition;

        3. The cerebral vaso-reactivity to arterial carbon dioxide tension in mechanically
           ventilated newborns to monitor induced changes in cerebral blood flow;

        4. The user-friendliness and loss of signal in routine care situations (e.g. during 24-hour
           monitoring of neonates undergoing intensive care).
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>June 2016</start_date>
  <completion_date type="Anticipated">April 2019</completion_date>
  <primary_completion_date type="Anticipated">September 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Cerebral tissue oxygen saturation (StO2) after birth.</measure>
    <time_frame>10 min immediately after umbilical cord clamping.</time_frame>
    <description>Measurement of cerebral haemodynamics immediately after birth.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Precision and repeatability</measure>
    <time_frame>During second day of life.</time_frame>
    <description>Test-retest variability estimated by within-subject standard deviation in one-way ANOVA with subject as factor.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Cerebral vaso-reactivity to arterial carbon dioxide</measure>
    <time_frame>1 hour after change in ventilator settings.</time_frame>
    <description>Mean CBFi and tcpCO2 one minute before the change and 15 min after will be used to analyse CBFi-tcpCO2 reactivity.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Assessment of user-friendliness and loss of signal in routine care</measure>
    <time_frame>24 hours of contineous measurements.</time_frame>
    <description>Assessed by Likert-scale questionnaire completed by clinical staff.</description>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Hemodynamic Instability</condition>
  <arm_group>
    <arm_group_label>Infants delivered by elective caesarean</arm_group_label>
    <description>Infants to be measured immediately after birth and on their second day of life.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Infants on mechanical ventilation</arm_group_label>
    <description>Infants to be measured while changing ventilator settings to normalize arterial pCO2.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Infants on ventilatory support</arm_group_label>
    <description>Infants to be measured for 24 hours continuously to assess user-friendliness and loss of signal.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>BabyLux Neuro-monitor</intervention_name>
    <description>Measurement of cerebral blood flow index (CBFi) and tissue oxygen saturation (StO2).</description>
    <arm_group_label>Infants delivered by elective caesarean</arm_group_label>
    <arm_group_label>Infants on mechanical ventilation</arm_group_label>
    <arm_group_label>Infants on ventilatory support</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Setting 1 and 2:

        Newborn infants immediately after delivery by elective caesarean and on their second day of
        life.

        Setting 3:

        Premature infants on mechanical ventilation.

        Setting 4:

        Neonate infants on ventilatory support
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Setting 1 and 2:

        Inclusion Criteria:

          -  GA &gt; 37 weeks

          -  planned to be delivered by an uncomplicated elective caesarean section

        Exclusion Criteria:

          -  need for resuscitation or supplementary oxygen during the first 10 minutes following
             umbilical cord clamping

          -  congenital malformations

        Setting 3:

        Inclusion Criteria:

          -  GA &lt; 37 weeks

          -  Postnatal age more &gt; 24 hours

          -  Mechanically ventilated

          -  Clinically stable

          -  Normal brain ultrasound

          -  Transcutaneous pCO2 monitoring (tcpCO2)

        Exclusion Criteria:

          -  Congenital malformations

        Setting 4:

        Inclusion Criteria:

          -  Postnatal age &lt; 28 days

          -  ventilatory support by mechanical ventilation or nasal CPAP

        Exclusion Criteria:

          -  Congenital malformations
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>4 Weeks</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gorm Greisen, MD, Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rigshospitalet, Denmark</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Gorm Greisen, MD, Prof.</last_name>
    <phone>+45 35 45 43 20</phone>
    <email>gorm.greisen@regionh.dk</email>
  </overall_contact>
  <location>
    <facility>
      <name>Rigshospitalet</name>
      <address>
        <city>Copenhagen</city>
        <zip>2100</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gorm Greisen, MD, Prof.</last_name>
      <phone>+45 35 45 43 20</phone>
      <email>gorm.greisen@regionh.dk</email>
    </contact>
    <contact_backup>
      <last_name>Bj√∏rn Andresen, MD</last_name>
      <phone>+45 28 94 73 45</phone>
      <email>bjoern.andresen@regionh.dk</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>IRCCS Ca'Granda Ospedale Maggiore Policlinico</name>
      <address>
        <city>Milan</city>
        <zip>20122</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Monica Fumagalli, MD</last_name>
      <email>monica.fumagalli@unimi.it</email>
    </contact>
    <contact_backup>
      <last_name>Agnese De Carli, MD</last_name>
      <email>agnese_decarli@yahoo.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Denmark</country>
    <country>Italy</country>
  </location_countries>
  <link>
    <url>http://www.babylux-project.eu</url>
    <description>The BabyLux project web-site</description>
  </link>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 23, 2016</study_first_submitted>
  <study_first_submitted_qc>June 23, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 28, 2016</study_first_posted>
  <last_update_submitted>April 10, 2018</last_update_submitted>
  <last_update_submitted_qc>April 10, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 11, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Rigshospitalet, Denmark</investigator_affiliation>
    <investigator_full_name>Gorm Greisen</investigator_full_name>
    <investigator_title>Professor, MD</investigator_title>
  </responsible_party>
  <keyword>Time-resolved spectroscopy</keyword>
  <keyword>Diffuse correlation spectroscopy</keyword>
  <keyword>Neonatology</keyword>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

